UK Markets open in 3 hrs 47 mins
NIKKEI 225
28,029.57 +276.20 (+1.00%) HANG SENG
23,766.69 -22.24 (-0.09%) CRUDE OIL
66.22 -0.28 (-0.42%) GOLD FUTURES
1,782.10 +21.40 (+1.22%) DOW
34,580.08 -59.71 (-0.17%) BTC-GBP
38,499.87 +1,294.96 (+3.48%)
Enochian Biosciences, Inc. (ENOB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 11.48 |
| Open | 11.56 |
| Bid | 9.25 x 1400 |
| Ask | 9.35 x 900 |
| Day's range | 9.29 - 11.65 |
| 52-week range | 2.80 - 13.78 |
| Volume | |
| Avg. volume | 219,501 |
| Market cap | 444.709M |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.23 |
| Earnings date | 11 May 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Enochian Biosciences (NASDAQ:ENOB) Using Debt In A Risky Way?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
- Investing.com
Enochian Gains As FDA Agrees To Give View On Potential Cure For Hepatitis B
By Dhirendra Tripathi
- Motley Fool
Why Enochian BioSciences Was a Winner on Monday
Biotech Enochian BioSciences (NASDAQ: ENOB) enjoyed a nice share price lift on Monday. Enochian explained that this technique is effected through a nanoparticle, which gives scope for either rapid treatment of an infection, or an "ambush" in which it effectively waits in a cell for infection, then strikes. This technology was developed by the biotech's co-founder Serhat Gumrukcu.
© 2021 Yahoo. All rights reserved.
